Sign in with your email address username.


The sources of pharmaceuticals for problematic users of benzodiazepines and prescription opioids


There are growing concerns in Australia and overseas about the increasing misuse of a range of pharmaceuticals, and associated harms.14 This includes the problematic use of benzodiazepines and prescription opioids in Australia.

Clients of drug treatment services are commonly reported to use a range of pharmaceuticals.57 For example, self-reported prevalence of benzodiazepine use among clients undergoing treatment for opioid use ranges from 66% to 100%,5,7,8 and use confirmed by urine drug testing ranges from 51% to 70%.8 Moreover, benzodiazepine use is associated with poorer treatment and health outcomes among opioid users.9,10 In North America, prescription opioid-dependent clients outnumber heroin-dependent clients among those presenting for methadone maintenance treatment.